The potential role for prolactin-inducible protein (PIP) as a marker of human breast cancer micrometastasis

British Journal of Cancer

Volumn 81, Issue 6, 1999, Pages 1002-1008

  Clark, J W ^a   Snell, L ^a   Shiu, R P C ^a   Orr, F W ^a   Maitre, N ^b   Vary, C P H ^c   Cole, D J ^b   Watson, P H ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

Breast cancer; Genetic marker; Micrometastases; Prolaction inducible protein; Reverse transcription polymerase chain reaction

Indexed keywords

ESTROGEN RECEPTOR; MESSENGER RNA; PROGESTERONE RECEPTOR; PROLACTIN INDUCIBLE PROTEIN; TUMOR MARKER; UNCLASSIFIED DRUG;

ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; BREAST DUCT; BREAST EPITHELIUM; BREAST METASTASIS; CANCER GRADING; CONTAMINATION; CONTROLLED STUDY; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LEUKOCYTE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVARY GLAND; SKIN; SOUTHERN BLOTTING; VEIN PUNCTURE;

APOLIPOPROTEINS; APOLIPOPROTEINS D; BREAST NEOPLASMS; CARRIER PROTEINS; FEMALE; GLYCOPROTEINS; HUMANS; MEMBRANE TRANSPORT PROTEINS; NEOPLASM METASTASIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 0032701216     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.bjc.6690799     Document Type: Article

References (41)

1. Bostick PJ, Chatterjee S, Chi DD, Huynh KT, Giuliano AE, Cote R and Hoon DS (1998) Limitations of specific reverse-transcriptase polymerase chain reaction markers in the detection of metastases in the lymph nodes and blood of breast cancer patients. J Clin Oncol 16: 2632-2640
2. Bundred NJ, Stewart HJ, Shaw DA, Forrest AP and Miller WR (1990) Relation between apocrine differentiation and receptor status, prognosis and hormonal response in breast cancer. Eur J Cancer 26: 1145-117
3. de Almeida PC and Pestana CB (1992) Immunohistochemical markers in the identification of metastatic, breast cancer. Breast Cancer Res Treat 21: 201-210
4. de Graaf H, Maclandsmo GM, Ruud P, Forus A, Oyjord T, Fodstad O and Hovig F. (1997) Ectopic expression of target genes may represent an inherent limitation of RT-PCR assays used for micrometastasis detection: studies on the epithelial glycoprotein gene EGP-2. Int J Cancer 72: 191-196
5. Dingemans AM, Brakenhoff RH, Postmus PE and Giaccone G (1997) Detection of cytokeratin-19 transcripts by reverse transcriptase-polymerase chain reaction in lung cancer cell lines and blood of lung cancer patients [see comments]. Lab Invest 77: 213-220
6. Elston CW and Ellis IO (1991) Pathological prognostic factors in breast cancer. I. The value of histological grade in breast cancer: experience from a large study with long-term follow-up. Histopathology 19: 403-410
7. Ercolani L, Florence B, Denaro M and Alexander M (1988) Isolation and complete sequence of a functional human glyceraldehyde-3-phosphate dehydrogenase gene. J Biol Chem 263: 15335-15341
8. Ferrari AC, Stone NN, Eyler JN, Gao M, Mandeli J, Unger P. Gallagher RE and Stock R (1997) Prospective analysis of prostate-specific markers in pelvic lymph nodes of patients with high-risk prostate cancer [see comments]. J Natl Cancer Inst 89: 1498-1504
9. Fiel MI, Cemaianu G, Burstein DE and Batheja N (1996) Value of GCDFP-15 (BRST-2) as a specific immunocytochemical marker for breast carcinoma in cytologic specimens. Acta Cytol 40: 637-641
10. Haagensen DF, Jr, Dilley WG, Mazoujian G and Wells SA, Jr (1990) Review of GCDFP-15, An apocrine marker protein. Ann NY Acad Sci 586: 161-173
11. Hall RE, Clements JA, Birrell SN and Tilley WD (1998) Prostate-specific antigen and gross cystic disease fluid protein-15 are co-expressed in androgen receptor-positive breast tumours. Br J Cancer 78: 360-365
12. Hiller T, Snell L and Watson PH (1996) Microdissection RT-PCR analysis of gene expression in pathologically defined frozen tissue sections. Biotechniques 21: 38-40, 42, 44
13. Hoon DS, Sarantou T, Doi F, Chi DD, Kuo C, Conrad AJ, Schmid P, Turner R and Guiliano A (1996) Detection of metastatic breast cancer by beta hCG polymerase chain reaction. Int J Cancer 69: 369-374
14. Leygue E, Snell L, Hiller T, Dotzlaw H, Hole K, Murphy LC and Watson PH (1996) Differential expression of psoriasin messenger RNA between in situ and invasive human breast carcinoma [published erratum appears in Cancer Res 1997 Feb 15; 57(4): 793]. Cancer Res 56: 4606-4609
15. Lockett MA, Baron PL, PH, OB, Elliott BM, Robison JG, Maitre N, Metcalf JS and Cole DJ (1998a) Detection of occult breast cancer micrometastases in axillary lymph nodes using a multimarker reverse transcriptase-polymerase chain reaction panel. J Am Coll Surg 187: 9-16
16. Lockett MA, Metcalf JS, Baron PL, PH, OB, Elliott BM, Robison JG and Cole DJ (1998b) Efficacy of reverse transcriptase-polymerase chain reaction screening for micrometastic disease in axillary lymph nodes of breast cancer patients. Am Surg 64: 539-543; discussion 543-544
17. Lopez-Guerrero JA, Bolufer-Gilabert P, Sanz-Alonso M, Barragan-Gonzalez E, Palau-Perez J, De la Rubia Comos J, Sempere-Talens A and Bonanad-Boix S (1997) Minimal illegitimate levels of cytokeratin K 19 expression in mononucleated blood cells detected by a reverse transcription PCR method (RT-PCR). Clin Chim Acta 263: 105-116
18. Manni A, Santen RJ, Boucher AE, Lipton A, Harvey H, Drago J, Rohner T, Haagensen D, Glode M and Santner SJ (1984) Evaluation of CEA and GCDFP-15 plasma level during hormonally induced cancer stimulation. Anticancer Res 4: 141-144
19. Mazoujian G, Bodian C, Haagensen DE, Jr and Haagensen CD (1989) Expression of GCDFP-15 in breast carcinomas. Relationship to pathologic and clinical Factors. Cancer 63: 2156-2161
20. Mazoujian G, Pinkus GS, Davis S and Haagensen DE, Jr (1983) Immunohistochemistry of a gross cystic disease fluid protein (GCDFP-15) of the breast. A marker of apocrine epithelium and breast carcinomas with apocrine features. Am J Pathol 110: 105-112
21. McGuckin MA, Cummings MC, Walsh MD, Hohn BG, Bennett IC and Wright RG (1996) Occult axillary node metastases in breast cancer: their detection and prognostic significance. Br J Cancer 73: 88-95
22. Min CJ, Tafra I. and Verbanac KM (1998) Identification of superior markers for polymerase chain reaction detection of breast cancer metastases in sentinel lymph nodes [In Process Citation]. Cancer Res 58: 4581-4584
23. Monteagudo C, Merino MJ, LaPorte N and Neumann RD (1991) Value of gross cystic disease fluid protein-15 in distinguishing metastatic breast carcinomas among poorly differentiated neoplasms involving the ovary. Hum Pathol 22: 368-372
24. Mori M, Mimori K, Ueo H, Karimine N, Barnard GF, Sugimachi K and Akiyoshi T (1996) Molecular detection of circulating solid carcinoma cells in the peripheral blood: the concept of early systemic disease. Int J Cancer 68: 739-743
25. Murphy LC, Lee-Wing M, Goldenberg GJ and Shiu RP (1987a) Expression of the gene encoding a prolactin-inducible protein by human breast cancers in vivo: correlation with steroid receptor status. Cancer Res 47: 4160-4164
26. Murphy LC, Tsuyuki D, Myal Y and Shiu RP (1987b) Isolation and sequencing of a cDNA clone for a prolactin-inducible protein (PIP). Regulation of PIP gene expression in the human breast cancer cell line, T 47D. J Biol Chem 262: 15236-15241
27. Noguchi S, Aihara T, Nakamori S, Motomura K, Inaji H, Imaoka S and Koyama H (1994) The detection of breast carcinoma micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Cancer 74: 1595-1600
28. Noguchi S, Aihara T, Motomura K, Inaji H. Imaoka S and Koyama H (1996) Detection of breast cancer micrometastases in axillary lymph nodes by means of reverse transcriptase-polymerase chain reaction. Comparison between MUCI mRNA and keratin 19 mRNA amplification. Am J Pathol 148: 649-656
29. Ormsby AH, Snow JL, Su WP and Goellner JR (1995) Diagnostic immunohistochemistry of cutaneous metastatic breast carcinoma: a statistical analysis of the utility of gross cystic disease fluid protein-15 and estrogen receptor protein. J Am Acad Dermatol 32: 711-716
30. Pagani A, Sapino A, Eusebi V, Bergnolo P and Bussolati G (1994) PIP/GCDFP-15 gene expression and apocrine differentiation in carcinomas of the breast. Virchows Arch 425: 459-465
31. Pelkey TJ, Frierson HF Jr and Bruns DE, (1996) Molecular and immunological detection of circulating tumor cells and micrometastases from solid tumors. Clin Chem 42: 1369-1381
32. Raj GV, Moreno JG and Gomella LG (1998) Utilization of polymerase chain reaction technology in the detection of solid tumors. Cencer 82: 1419-1442
33. Schoenfeld A, Kruger KH, Gomm J, Sinnett HD, Gazet JC, Sacks N, Bender HG, Luqmani Y and Coombes RC (1997) The detection of micrometastases in the peripheral blood and bone marrow of patients with breast cancer using immunohistochemistry and reverse transcriptase polymerase chain reaction for keratin 19. Eur J Cancer 33: 854-861
34. Soomro S and Shousha S (1992) Monoclonal antibody B72.3 immunostaning of breast carcinoma. Patterns of staining and relationship to mucin content and GCDFP-15 reactivity. Arch Pathol Lab Med 116: 32-35
35. Tsuchiya A, Sugano K, Kimijima I and Abe R (1996) Immunohistochemical evaluation of lymph node micrometastases from breast cancer. Acta Oncol 35: 425-428
36. Vary CP, Carmody M, LeBlanc R, Hayes T, Rundell C and Keilson I. (1996) Allele, specific hybridization of lipoprotein lipase and factor-V Leiden missense mutations with direct label alkaline phosphatase-conjugated oligonueleotide probes. Genet Anal 13: 59-65
37. Viacava P, Naccarato AG and Bevilacqua G (1998) Spectrum of GCDFP-15 expression in human fetal and adult normal tissues. Virchows Arch 432: 255-260
38. Walson PH, Snell L and Parisien M (1996) The NCIC Manitoba Breast Tumor Bank: a resource for applied cancer research. Cmaj 155: 281-283
39. Wick MR, Lillemoe TJ, Copland GT, Swanson PE, Manivel JC and Krang DT (1989) Gross cystic disease fluid protein-15 as a marker for breast cancer: immunohistochemical analysis of 690 human neoplasms and comparison with alpha-lactalbumin. Hum Pathol 20: 281-287
40. Wick MR, Ockner DM, Mills SE, Ritter JH and Swanson PF. (1998) Homologous carcinomas of the breasts, skin, and salivary glands. A histologic and immunohistochemical comparison of ductal mammary carcinoma, ductal sweat gland carcinoma, and salivary duct carcinoma. Am J Clin Pathol 109: 75-84
41. Zippelius A, Kufer P, Honold G, Kollermann MW, Oberneder R, Schlimok G, Riethmuller G and Pantel K (1997) Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708